{
    "SPADE_N_14110": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14110",
            "Peptide Name": "AS-14 (synthetic AMPs AS-18 analog, Lys-rich; XXA, UCLL1c)",
            "Source": "sequence truncation, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "GLFKKLRRKIKKGF",
            "Sequence Length": 14,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Anti-MRSA"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1719.17,
            "PI": 12.0,
            "Hydrophobicity": -0.83,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Zhang M, Wang J, Li C, Wu S, Liu W, Zhou C, Ma L.2024",
                    "Reference": "Probiotics Antimicrob Proteins. 2024 Apr 8. doi: 10.1007/s12602-024-10250-2.PubMed",
                    "Title": "Cathelicidin AS-12W Derived from the Alligator sinensis and Its Antimicrobial Activity Against Drug-Resistant Gram-Negative Bacteria In Vitro and In Vivo."
                }
            ],
            "Frequent Amino Acids": "KFG",
            "Absent Amino Acids": "ACDEHMNOPQSTUVWY",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 5,
            "Polar Residues": 7,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is most similar (77.78%) toAS-18obtained by continued C-terminal sequence truncation of AS-18. K: 36%; L=F=R: 14%.Activity: active against E. coli ATCC 25922 or 4 clinical strains (MIC 16-32 ug/ml), P. aeruginosa ATCC 27853 or 4 clinical strrains (MIC 8-64 ug/ml),  K. pneumoniae ATCC 13883 (MIC 64-128 ug/ml), A. baumannii (MIC 64 ug/ml), Gram+ S. aureus ATCC 29213 (MIC 16 ug/ml), MRSA (MIC 16 ug/ml), S.epidermidis (MIC >128 ug/ml), and C. albicans (MIC 8 ug/ml) ATCC 10231 >128 ug/ml.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06444",
                    "Similarity": 1.0,
                    "Sequence": "RRGLFKKLRRKIKKGFKKIFKRLPPVGVGVSIPLAGRR"
                },
                {
                    "SPADE_ID": "SPADE_N_12261",
                    "Similarity": 1.0,
                    "Sequence": "FFPIVKKLLSGLF"
                },
                {
                    "SPADE_ID": "SPADE_N_12271",
                    "Similarity": 1.0,
                    "Sequence": "LFPIVKKLLNGLF"
                }
            ]
        }
    }
}